Jai Patel is the founder of Imbria Pharmaceuticals. Imbria Pharmaceuticals has raised $144M in total funding. Latest round: Series B.
Jai Patel, MRCUP(UK), is the Chief Marketing Officer (CMO) at Imbria Pharmaceuticals, a clinical-stage biopharmaceutical company. The company focuses on developing novel therapies to enhance cellular energetics for treating major forms of heart disease and specific inborn errors of metabolism. Patel announced a significant milestone for Imbria with the first patient dosed in their IMPROVE-HCM study, following the recruitment of initial patients in the IMPROVE-DiCE study. This highlights Imbria's progress in clinical trials for their investigational cardiac mitotrope, IMB-101.
Full founder directory · Investor directory · Company funding database · Fundraising library